Ignite Creation Date:
2024-05-06 @ 8:06 PM
Last Modification Date:
2024-10-26 @ 3:20 PM
Study NCT ID:
NCT06250608
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-02-09
First Post:
2024-01-30
Brief Title:
Evaluation of rSO2 Between Frontal Lesion Area and Normal Area of Brain by NIRSITX Using NIRS in Acute Ischemic Stroke Patients
Sponsor:
OBELAB Inc
Organization:
OBELAB Inc
Study Overview
Official Title:
Evaluation of Cerebral Oxygen SaturationrSO2 Measurements Between Frontal Lesion Area and Normal Area of Brain by Pulse OximetryNIRSITX Using Near-infrared Spectroscopy in Acute Ischemic Stroke Patients Prospective Single-center Non-randomized Open-label Exploratory Clinical Trial
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The clinical trial is for acute ischemic stroke patients measuring cerebral oxygen saturation rSO2 values using pulse oximeter of near-infrared spectroscopy in the frontal lesion area and normal area of brain The purpose of the clinical trial is to compare differences in cerebral oxygen saturation values and the efficacy and safety are evaluated through additional exploratory clinical trials
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None